ELF Beauty is hoping that investors think its focus on affordable cosmetics with an upscale feel and strong U.S. cosmetics market is a sexy combination. Started as an online cosmetics seller over a decade ago, today ELF Beauty has over 11 retail stores across New York City and Los Angeles, and its foot in the door with major mass retailers such as Walmart (WMT) , Target (TGT) and CVS Health (CVS) . Target is ELF's longest standing national retail distribution partner, and represents about 23% of its sales. The company inked a deal to sell its offerings -- which mostly sell for $6 or less -- at Walmart in 2012, and the business has quickly grown to 28% of its annual business. Sales for the six months ended have tallied $96.8 million, up from $75.2 million a year earlier. Unlike many early stage growth companies going public, ELF Beauty is decently profitable. The company already works with Amazon (AMZN) , too, which is good news in light of the e-commerce giant recently launching a one-hour cosmetics delivery service in Chicago for Prime members. The health of the U.S. cosmetics markets should make ELF's expansion efforts a touch easier. The U.S. make-up market is anticipated to grow by a compound annual growth rate of 3.8% from 2013 to 2018, reaching $8.4 billion, according to research firm MarketResearch. TheStreet's Brian Sozzi has details from the New York Stock Exchange.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.